Haleon highlighted consistent market share gains in China as it reported third-quarter results.
A double-digit gain in China helped Haleon deliver mid-single-digit sales growth in the third quarter.
Join thousands of industry professionals who rely on HBW Insight for daily insights
Already a subscriber?
Haleon now holds 88% of its China OTC joint venture after acquiring a larger stake in the business from its local partners.
APAC health agencies such as WHO and Thailand's FDA are on board with the self-care agenda, and see it as crucial to achieving universal health coverage.
Haleon highlighted consistent market share gains in China as it reported third-quarter results.
Joint venture business which markets Haleon's OTC drug brands in China will soon be 88% owned by the UK-based firm.
HHS Secretary Robet F. Kennedy Jr. and FDA Commissioner Marty Makary to announce planned changes as “a major step forward” as part of Kennedy’s “Make America Healthy Again” campaign President Trump has adopted for his administration.
Major Europe-based consumer health players Haleon, Reckitt and Bayer feature in this sales and earnings preview, which highlights what to look out for as these three firms report their Q1 2025 results over the coming weeks.
CRN/Radicle Science expand Trailblazer Award nominations; BodyArmor brand relaunch with ‘Choose Better’ campaign and pro athletes; and Just Ingredients catches Bryce Harper as partner.
